A Phase 3 Study of LY2189265 Compared to Insulin Glargine in Patients With Type 2 Diabetes Mellitus on a Sulfonylurea and/or Biguanide
Phase of Trial: Phase III
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Dulaglutide (Primary) ; Biguanides; Insulin glargine; Sulfonylureas
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Sponsors Eli Lilly
- 10 Jun 2017 Biomarkers information updated
- 01 Jul 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 07 Mar 2013 Actual initiation date changed from 1 Jan 2012 to 1 Apr 2012 as reported by ClinicalTrials.gov.